BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4916023)

  • 21. [Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Klein HO
    Hamatol Bluttransfus; 1976; 18():135-45. PubMed ID: 786808
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experiences with vincristine sulfate in the therapy of malignant tumors].
    Hartwich G; Richter K; Lutz H
    Fortschr Med; 1972 Dec; 90(35):1305-9. PubMed ID: 4572046
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical experience in the treatment of malignant lymphomas with Vinca rosea alkaloids].
    Prato V; Mazza U; Uslenghi E; Battistini V; Bianco G
    Cancro; 1968; 21():Suppl 6:79-85. PubMed ID: 4906145
    [No Abstract]   [Full Text] [Related]  

  • 24. [The use of vinblastine and vincristine in the combined therapy of tumors].
    Cardinali G; Nervi C
    Tumori; 1968; 54(5):345-51. PubMed ID: 4884251
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
    Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
    Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555
    [No Abstract]   [Full Text] [Related]  

  • 26. The treatment of chronic lymphocytic leukaemia and malignant lymphomas with dipine.
    Cattaneo N; De Cataldo F; Pensabene A; Tiso R
    Oncology; 1967; 21(1):61-71. PubMed ID: 4870984
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ambulatory endoxan therapy by high doses].
    Fischer M; Martin H; Schubert JC
    Dtsch Med Wochenschr; 1967 Jun; 92(25):1145-50. PubMed ID: 5338225
    [No Abstract]   [Full Text] [Related]  

  • 28. Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
    De Vita VT; Canellos GP; Schein PJ; Chabner BA; Bagley CM; Young RC
    Proc Natl Cancer Conf; 1972; 7():379-90. PubMed ID: 4587651
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
    Hansen MM; Hertz H; Videaek A
    Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
    [No Abstract]   [Full Text] [Related]  

  • 30. [Association of nitrogen mustard, vincristine, methylhydrazine and prednisone in treatment of diffuse forms of Hodgkin's disease and ganglionic sarcomas].
    Goudemand M; Sautière-Habay D; Bauters F; Lerche-Habart B
    Lille Med; 1968 Dec; 13(10):1102-7. PubMed ID: 4886051
    [No Abstract]   [Full Text] [Related]  

  • 31. Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
    Luce JK; Gamble JF; Wilson HE; Monto RW; Isaacs BL; Palmer RL; Coltman CA; Hewlett JS; Gehan EA; Frei E
    Cancer; 1971 Aug; 28(2):306-17. PubMed ID: 4935774
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of milurit in hyperuricemia in patients with malignant hemopathies].
    Poddubnaia IV; Mansurov AN; Fominykh VG
    Klin Med (Mosk); 1975 Mar; 53(3):94-9. PubMed ID: 1090781
    [No Abstract]   [Full Text] [Related]  

  • 33. Vincristine treatment of advanced cancer: a cooperative study of 392 cases.
    Holland JF; Scharlau C; Gailani S; Krant MJ; Olson KB; Horton J; Shnider BI; Lynch JJ; Owens A; Carbone PP; Colsky J; Grob D; Miller SP; Hall TC
    Cancer Res; 1973 Jun; 33(6):1258-64. PubMed ID: 4352365
    [No Abstract]   [Full Text] [Related]  

  • 34. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S; Esposito R; Ponti GB; Giangrande A
    Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract]   [Full Text] [Related]  

  • 35. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults.
    Ellison RR; Holland JF; Weil M; Jacquillat C; Boiron M; Bernard J; Sawitsky A; Rosner F; Gussoff B; Silver RT; Karanas A; Cuttner J; Spurr CL; Hayes DM; Blom J; Leone LA; Haurani F; Kyle R; Hutchison JL; Forcier RJ; Moon JH
    Blood; 1968 Oct; 32(4):507-23. PubMed ID: 4879053
    [No Abstract]   [Full Text] [Related]  

  • 36. Combination chemotherapy of advanced lymphomas.
    Kurnick JE; Robinson WA
    Arch Intern Med; 1972 Jun; 129(6):908-13. PubMed ID: 5067727
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II study of hexamethylmelamine in refractory Hodgkin's disease, other lymphomas, and chronic lymphocytic leukemia.
    Omura GA; Broun GO; Papps J; Birch R
    Cancer Treat Rep; 1981; 65(11-12):1027-9. PubMed ID: 6794907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination chemotherapy with methotrexate, endoxan, and vincristine (M.E.V.) in the treatment of non-Hodgkin's lymphoma (author's transl)].
    Lauria F; Baccarani M; Barbieri E; Fiacchini M; Tura S
    Tumori; 1973; 59(6):401-8. PubMed ID: 4598587
    [No Abstract]   [Full Text] [Related]  

  • 39. [Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
    Danieli G
    G Clin Med; 1966 Aug; 47(8):732-68. PubMed ID: 4865460
    [No Abstract]   [Full Text] [Related]  

  • 40. The place of chemotherapy in Hodgkin's disease and allied disorders.
    Wiltshaw E; Millett Y
    Proc R Soc Med; 1972 Dec; 65(12):1110. PubMed ID: 4568541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.